Is a complete LON/0IL8 research report available?

No complete published report is available for lon/0IL8 (LON/0IL8) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0IL8 (LON/0IL8)

London Stock Exchange: LON/0IL8 · USD

$8.38

-0.12 (-1.4%)· Recorded snapshot

Market cap	24.6M
Revenue (ttm)	3.5M
Net income (ttm)	138.1M
EPS (ttm)	$34.1
P/E (trailing)	0.2x
Volume	1,257
Beta	1.04

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.5M
Net income (ttm): 138.1M
EPS (ttm): $34.1
P/E (trailing): 0.2x
Market cap: 24.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-09 02:00 UTC

All LON/0IL8 indicators

Market & fundamental data

Available fields

168

Groups with data

Currency

USD

Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	34
Employees Change	-191%
Employees Change Percent	-84.89
Enterprise value	$-26.6M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US31572Q8814
Last refreshed	2026-09-09
Market cap	$24.6M
Price	$8.38
Price currency	USD
Rev Per Employee	102,325.85x
Sector	Healthcare
Sector PE	21.4
Sector PE Fwd	13.66
Sic	2836
Symbol	lon/0IL8
Website	https://www.kyntrabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	561.97%
FCF yield	-116.76%
P/B ratio	-4x
P/E ratio	0.18x
P/S ratio	7.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-17M
Net Income	$138.1M
Net Income Growth Quarters	1%
Net Income Growth Years	3%
Pretax Margin	-669.71%
Profit Margin	3,968.63%
Profit Per Employee	$4.1M
Profitable Quarters	$1
Profitable Years	1
ROA	-22.5
Roa5y	-27.5
ROCE	-77.26
ROIC	-68.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-29.07%
Cagr3y	-30.69%
Cagr5y	-51.24%
EPS Growth Quarters	1
EPS Growth Years	4
Revenue Growth	-37.16x
Revenue Growth Years	0x
Revenue Growth3 Y	-67.18x
Revenue Growth5 Y	-51.49x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.03
Assets	$76.2M
Cash	$68.8M
Current Assets	$71.5M
Current Liabilities	$26.6M
Debt	$0
Equity	$-6.1M
Interest Coverage	-5.41
Liabilities	$82.3M
Long Term Assets	$4.7M
Long Term Liabilities	$55.7M
Net Cash	$68.8M
Net Cash By Market Cap	$280
Tangible Book Value	$-22.7M
Tangible Book Value Per Share	$-5.61
WACC	9.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.69
Inventory Turnover	7.5
Net Working Capital	$-23M
Quick ratio	2.54
Working Capital	$45.8M
Working Capital Turnover	$0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-29.05%
200-day SMA	7.66
3Y total return	-66.72%
50-day SMA	7.41
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.24%
All Time High	1,697.5
All Time High Change	-99.5%
All Time High Date	2018-07-09
All Time Low	5.97
All Time Low Change	42.37%
All Time Low Date	2025-04-09
ATR	0.37
Beta	1.04
Ch YTD	-1.85
High	8.54
High52	12.55
High52 Date	2025-09-29
High52ch	-33.18%
Low	8.34
Low52	6.29
Low52 Date	2026-05-29
Low52ch	33.27%
Ma50ch	14.72%
Price vs 200-day SMA	10.92%
RSI	65.75
RSI Monthly	34.6
RSI Weekly	58.98
Sharpe ratio	-0.31x
Sharpe Ratio3y	-0.04x
Sortino ratio	-0.33
Sortino Ratio3y	-0
Total Return	-0.32%
Tr YTD	-1.85
Tr1m	22.51%
Tr1w	5.59%
Tr3m	21.85%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,562,187%
Net Borrowing	-59,480,160.4
Shares Insiders	2.15%
Shares Institutions	12.31%
Shares Qo Q	0.02%
Shares Yo Y	0.32%
Short Ratio	4.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-31.7M
Adjusted OCF	-31,684,794
Average Volume	793.95x
Bv Per Share	-5.61
CAPEX	$-6,783
Ch1m	22.51
Ch1w	5.59
Ch1y	-29.05
Ch3m	21.86
Ch3y	-66.72
Ch5y	-97.24
Ch6m	23.01
Change	-1.38%
Change From Open	0.03
Close	8.5
Days Gap	-1.41
Depreciation Amortization	157,269
Dollar Volume	10,537.2
Earnings Date	2026-08-13
EBIT	$-37.9M
EBITDA	$-37.7M
EPS	$34.12
F Score	3
FCF	$-28.7M
FCF EV Yield	107.85x
Financing CF	-64,775,239
Fiscal Year End	December
Founded	1,993
Income Tax	$-754
Investing CF	42,311,964
Is Primary Listing	0
Last Earnings Date	2026-08-13
Last Report Date	2026-06-30
Last Split Date	2025-06-17
Last Split Type	Reverse
Ma150	7.27
Ma150ch	17%
Ma20	7.62
Ma20ch	11.54%
Net CF	-52,153,779
Next Earnings Date	2026-11-09
Open	8.38
Position In Range	21.4
Price Date	2026-09-08
Relative Volume	1.58x
Revenue	3,479,079x
SBC By Revenue	86.35x
Share Based Comp	3,004,248
Tax By Revenue	-0.02x
Tr6m	23.01%
Volume	1,257
Z Score	-24.36

LON/0IL8 (LON/0IL8)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0IL8

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0IL8 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0IL8

Frequently asked questions